IP Library Granted Patent US 8,679,688
Granted Patent B2
US 8,679,688 · App. 13/862,153 · Granted Mar 25, 2014

Biological fuel cell and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,679,688
App. No.
13/862,153
Granted
Mar 25, 2014
Kind
B2
Abstract

A fuel cell has an anode and a cathode with anode enzyme disposed on the anode and cathode enzyme is disposed on the cathode. The anode is configured and arranged to electrooxidize an anode reductant in the presence of the anode enzyme. Likewise, the cathode is configured and arranged to electroreduce a cathode oxidant in the presence of the cathode enzyme. In addition, anode redox hydrogel may be disposed on the anode to transduce a current between the anode and the anode enzyme and cathode redox hydrogel may be disposed on the cathode to transduce a current between the cathode and the cathode enzyme.

Claims (24)

1. An electrochemical cell for positioning in a biological system comprising oxygen, comprising:

a substrate comprising a first face and a second face;

an anode disposed on the first face of the substrate, wherein the anode comprises an anode enzyme and a mediator, wherein the enzyme and the mediator are crosslinked; and

a cathode disposed on the second face of the substrate.

2. The electrochemical cell according to claim 1 , wherein the mediator is a metallocene derivative.

3. The electrochemical cell according to claim 2 , wherein the metallocene derivative is ferrocene.

4. The electrochemical cell according to claim 1 , wherein the mediator comprises a transition metal complex.

5. The electrochemical cell according to claim 4 , wherein the transition metal complex comprises ruthenium or osmium.

6. The electrochemical cell according to claim 1 , wherein the anode comprises a conductive material selected from the group consisting of gold, carbon, platinum, ruthenium dioxide and palladium.

7. The electrochemical cell according to claim 6 , wherein the anode comprises carbon or gold.

8. The electrochemical cell according to claim 1 , wherein the substrate surface is roughened.

9. The electrochemical sensor according to claim 1 , wherein the anode enzyme is a glucose-responsive enzyme.

10. The electrochemical cell according to claim 9 , wherein the glucose-responsive enzyme is glucose oxidase or glucose dehydrogenase.

11. The electrochemical cell according to claim 9 , wherein the glucose-responsive enzyme further comprises an enzyme cofactor.

12. The electrochemical cell according to claim 11 , wherein the enzyme cofactor is pyrroloquinoline quinone (PQQ).

13. The electrochemical cell according to claim 1 , wherein the cathode comprises platinum.

14. The electrochemical cell according to claim 1 , wherein the cathode further comprises a cathode enzyme.

15. The electrochemical cell according to claim 14 , wherein the cathode enzyme is an enzyme selected from the group consisting of tyrosinase, horseradish peroxidase, soybean peroxidase, laccase and cytochrome C peroxidase.

16. The electrochemical cell according to claim 15 , wherein the cathode enzyme is laccase or cytochrome C peroxidase.

17. The electrochemical cell according to claim 1 , wherein at least a portion of the electrochemical cell is configured to be subcutaneously positioned in a subject.

18. The electrochemical cell according to claim 1 , wherein the electrochemical cell further comprises a mass transport limiting membrane disposed over the anode and cathode.

19. The electrochemical cell according to claim 18 , wherein the mass transport limiting membrane is configured to limit contact of macromolecules of 5000 daltons or greater with the anode and cathode.

20. The electrochemical cell according to claim 18 wherein the mass transport limiting membrane is a hydrogel.

21. The electrochemical cell according to claim 20 , wherein the hydrogel comprises at least 20 wt % fluid when in equilibrium with analyte-containing fluid.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2013
From: HELLER, ADAM
To: E. HELLER & COMPANY
Reel/Frame 030830/0495 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2013
From: E. HELLER & COMPANY
To: THERASENSE, INC.
Reel/Frame 030830/0541 →
RATIFICATION OF ASSIGNMENT Recorded Jul 18, 2013
From: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM; THERASENSE INC.
To: THERASENSE, INC.
Reel/Frame 030831/0962 →
CHANGE OF NAME Recorded Jul 18, 2013
From: THERASENSE, INC.
To: ABBOTT DIABETES CARE INC.
Reel/Frame 030832/0001 →